Publication | Closed Access
First demonstration of anti-lymphoma activity of BCL-2 antisense molecule-G3139; Results of phase I/IIA clinical trial
320
Citations
0
References
1997
Year
Hematological MalignancyLymphoid NeoplasiaMedicineAnti-lymphoma ActivityImmunologyPathologyAnti-cancer AgentFirst DemonstrationOncologyCancer ResearchTumor BiologyBcl-2 Antisense Molecule-g3139
No additional data available for this publication yet. Check back later!